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Veratridine produces distinct 
calcium response profiles in mouse 
Dorsal Root Ganglia neurons
Zainab A. Mohammed, Ciara Doran, David Grundy & Mohammed A. Nassar
Nociceptors are a subpopulation of dorsal root ganglia (DRG) neurons that detect noxious stimuli and 
signal pain. Veratridine (VTD) is a voltage-gated sodium channel (VGSC) modifier that is used as an 
“agonist” in functional screens for VGSC blockers. However, there is very little information on VTD 
response profiles in DRG neurons and how they relate to neuronal subtypes. Here we characterised 
VTD-induced calcium responses in cultured mouse DRG neurons. Our data shows that the heterogeneity 
of VTD responses reflects distinct subpopulations of sensory neurons. About 70% of DRG neurons 
respond to 30–100 μM VTD. We classified VTD responses into four profiles based upon their response 
shape. VTD response profiles differed in their frequency of occurrence and correlated with neuronal 
size. Furthermore, VTD response profiles correlated with responses to the algesic markers capsaicin, 
AITC and α, β-methylene ATP. Since VTD response profiles integrate the action of several classes of ion 
channels and exchangers, they could act as functional “reporters” for the constellation of ion channels/
exchangers expressed in each sensory neuron. Therefore our findings are relevant to studies and screens 
using VTD to activate DRG neurons.
Dorsal Root Ganglia (DRG) contain a heterogeneous population of sensory neurons that detect noxious and 
innocuous stimuli. DRG neurons that respond to noxious stimuli are known as nociceptors. Inflammation and 
nerve injury sensitise sensory neurons and result in hyperalgesia and allodynia1,2. Understanding the physiology 
and pathophysiology of nociceptors is important for the development of analgesic drugs. Nociceptors express 
multiple subtypes of voltage-gated sodium channels (VGSCs) which are a key determinant of their excitability. 
Inflammation and injury-induced sensitisation of nociceptors is in part mediated through changes in expression 
and/or properties of VGSCs1–3.
Drug screens for VGSC blockers use functional assays to test their sensitivity. These include FLIPR, cal-
cium imaging and patch clamp electrophysiology; and employ Veratridine (VTD) as a VGSC “agonist” to test 
the pharmacological properties of candidate VGSC ligands4. VTD is a natural, lipid-soluble alkaloid from the 
Liliaceae family that binds to the S6 in Domain I and IV of VGSCs; a site-2 neurotoxin4–6. VTD binds to open 
VGSCs and prevents the channels from entering into the inactivated state7–9. VTD acts predominantly on 
tetrodotoxin-sensitive (TTX-S) VGSCs10. Despite its wide use there is little information on how VTD responses 
relate to the different subpopulations of DRG neurons; particularly nociceptors. Given the functional and molec-
ular heterogeneity of DRG neurons we hypothesised that VTD produces heterogeneous responses in primary 
sensory neurons. A better characterisation of the VTD responses in DRG neurons may provide a novel functional 
classification of sensory neurons.
Results
Veratridine produces TTX-sensitive responses. VTD elicited heterogeneous calcium responses that 
differed in their profile and onset in sensory neurons, Fig. 1A. This is in contrast to the homogenous response 
profile elicited in the neuroblastoma cell lines N2a11 and SH-SY5Y12, which are commonly used mouse and 
human neuronal cell lines (respectively), Fig. 1B,C. Different concentrations of VTD ranging from 15 to 200 μM 
have been used to activate VGSCs in a variety of cell types7,10,13–15. We therefore examined a wide range of VTD 
concentrations (0.001, 0.1, 1, 10, 30, and 100 μ M) on cultured mouse DRG neurons. Since 200 μ M VTD has 
been shown to inhibit voltage-gated potassium channels (VGKCs)13 we did not use concentrations greater than 
100 μM. There was a concentration dependent increase in the number of responding neurons from a threshold of 
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Figure 1. Veratridine elicits TTX-sensitive calcium responses in DRG neurons. (A) Example traces of 
ratiometric (F350/380) increases in Fura-2 fluorescence following application of 30 μ M veratridine (VTD) and 
40 mM KCl to cultured DRG neurons, Nueroblastoma-2a (N2a) cells (B) and SH-5Y5 cells (C). Each trace 
represents the response of a single cell. VTD but not solvent (ethanol) elicited responses of heterogeneous 
profiles in DRG neurons but not in any of the cell lines. (D) Percentages of neurons activated by a range of 
VTD concentrations from potassium responsive neurons. Response rates are 5.4 ± 3 for 1 μ M (20/303 cells), 
37.8 ± 9 for 10 μ M (131/325 cells), 77.2 ± 4 for 30 μ M (119/151 cells) and 87.5 ± 0.3 for 100 μ M (272/311 cells); 
from N = 2 mice. One-way analysis of variance with Tukey’s post-test, *P < 0.05, **P < 0.01 and ***P < 0.001. 
(E) Example traces of response to 30 μ M VTD in presence and then absence of 0.3 μ M Tetrodotoxin (TTX). 
(F) An example trace of a neuron responding to VTD in the presence of 0.3 μ M TTX. (G) TTX blocked 92% of 
VTD responses. Only 8 ± 2 (10/98 cells) of neurons responded to VTD in the presence of TTX. Data shown are 
mean ± SEM, Two-tailed paired Student’s t-test, ****P < 0.0001.
www.nature.com/scientificreports/
3Scientific RepoRts | 7:45221 | DOI: 10.1038/srep45221
1 μ M to which 5% of neurons responded. 10 μ M elicited a response in 38% of neurons while 30 μ M and 100 μM 
VTD elicited responses in 77% and 88% of neurons, respectively, Fig. 1D. Subsequent experiments were per-
formed using 30 μ M VTD because of the robust response at this concentration and to minimise potential effects 
on VGKCs. Responses to 30 μ M VTD varied in latency from 30 to 150 seconds as shown in the example traces 
in Fig. 1A. Therefore, we standardised the period of VTD application to three minutes. Pre-treatment of neu-
rons with TTX (0.3 μ M) blocked VTD responses in 92% of VTD-responsive neurons, Fig. 1E–G. Of note, VTD 
responses elicited in the presence of TTX had a response profile characterised by a single peak with a delayed 
onset (towards the end of the 3 minutes of VTD application period), Fig. 1F.
Veratridine produces four distinct calcium response profiles that occur at different frequencies. 
We classified VTD responses into four distinct profiles, Fig. 2A. Three profiles were characterised by a single peak 
with a rapid rise in intracellular calcium [Ca]i levels but differed in their decay rate. The Slow Decay (SD) profile 
returned to baseline over 15–40 min following VTD washout, Fig. 2A (blue). In the Intermediate Decay (ID) pro-
file, calcium responses returned to baseline within 2–5 min, Fig. 2A (purple). The Rapid Decay (RD) profile was 
characterised by a transient [Ca]i peak which returned to baseline during the application period, Fig. 2A (green). 
The fourth profile was characterised by a multi-peak response which we thus called the Oscillatory profile (OS), 
Fig. 2A (red). In some OS neurons the response ended prior to the end of VTD application while in others it 
continued to oscillate during the wash. The four VTD response profiles varied in their frequency of occurrence. 
The OS profile was the most frequent accounting for 48% of all VTD-responsive neurons, followed by the SD 
profile (24%) and equal frequencies for the ID and RD profiles (13% each), Fig. 2B. Furthermore, the four profiles 
differed in their onset, calculated as the latency to peak from the start of VTD application. The RD profile had 
the longest latency which was twice that of the other three profiles, Fig. 2C. The onset difference was inherent 
to neurons and not due to variation in the rate of perfusion since all neurons responded with the same latency 
to high potassium. A very small number of VTD-responsive neurons had a “ramp” like profile characterised by 
a very slow rise and decay of [Ca]i levels (not shown). These neurons were classified as “undefined” in further 
experiments and were not included in our characterisation because they were too infrequent (less than 1%) to 
include in our analysis and draw any conclusions about.
Figure 2. Veratridine produces four calcium response profiles that differ in their frequency of occurrence 
and latency to peak. (A) Representative traces of the four VTD response profiles observed in cultured DRG 
neurons. SD (slow decay) in blue has the slowest decay rate of calcium signal, followed by ID (intermediate 
decay) in purple and then RD (rapid decay) in green. Responses with two or more peaks are called oscillatory 
(OS) in red. (B) Frequency of occurrence of the four VTD response profiles in VTD-responsive neurons (N = 8 
mice, 494 cells). The OS profile is the most frequent (48 ± 4%), followed by the SD profile (24.4 ± 4%). The RD 
(13.4 ± 4%) and ID (12.7 ± 2%) profiles have similar frequencies. (C) Mean response latency for the four VTD 
response profiles (N = 3 mice, 143 cells). Only neurons that have the same onset to KCl were included in this 
analysis to exclude differences due to rate of perfusion. The RD (115.4 ± 15 s) profile has the longest latency 
while the SD (34.2 ± 5 s), ID (55.8 ± 13 s) and OS (43.5 ± 4 s) profiles have similar latencies. Data shown are 
mean ± SEM. One-way analysis of variance with Tukey’s post-test, ***P < 0.001 and ****P < 0.0001.
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The Veratridine SD response profile is enriched in large diameter neurons. DRG neurons are 
classified according to their soma size into small, medium and large diameter neurons16–18. Soma size of DRG 
neurons correlates with functional modalities. Small and medium sized neurons tend to be nociceptors and 
innocuous thermoreceptors, while large diameter neurons are more likely to be proprioceptors and low threshold 
mechanoreceptors19,20. Neuronal soma size in our DRG cultures ranged from 10 to 45 μ m. Analysis of soma size 
and VTD response profiles showed that although the SD profile occurs in all neuronal sizes (mean 25 μ m), it was 
the most prevalent profile in neurons larger than 30 μ m in diameter (82% of these neurons had the SD profile). 
Neurons with the RD, OS and ID profiles had the narrowest size range with almost all smaller than 30 μ m in 
diameter (100, 99 and 91%, respectively). The mean soma diameter of neurons with the RD, OS and ID VTD 
response profiles was smaller than that of SD neurons (RD 21 μ m, OS 20 μ m and ID 21 μ m), Fig. 3A–C. Of note, 
the majority (94%) of VTD-unresponsive neurons were smaller than 30 μ m (mean 21 μ m), Fig. 3D.
The Veratridine SD and RD response profiles are under-represented in capsaicin sensitive neurons. 
We next investigated how the four VTD response profiles correlate with a commonly used functional marker 
of nociceptors. Capsaicin is a TRPV1 agonist used to activate peptidergic nociceptors21. In order to examine 
the relationship between VTD response profiles and sensitivity to capsaicin we applied them sequentially in a 
single calcium imaging protocol as illustrated in Fig. 4A. The order in which the two agonists were applied did 
not influence the proportion of responding neurons nor the frequency of occurrence of VTD response profiles, 
Supplementary Fig. S1. Therefore, we combined results from both experiments in subsequent analysis, Fig. 4B. 
The frequency of occurrence of the four response profiles in these neurons was in the same order as obtained 
without capsaicin, Fig. 4C. The percentage of capsaicin sensitive neurons in our cultures (32%) is comparable to 
published reports22. Capsaicin sensitive neurons were approximately twice as likely to respond to VTD (156 of 
223, 70%) than not (67 of 223, 30%), Fig. 4B. We next examined VTD-responsive neurons for the relationship 
between each of the four VTD response profiles and capsaicin sensitivity. The proportions of capsaicin-sensitive 
Figure 3. Veratridine OS, RD and ID response profiles occur in neurons smaller than 30 μ m in diameter.  
(A) Histogram of soma diameter distribution of neurons with the SD profile in blue (mean 42.9 ± 1, 
median = 23.1 μ m; 79 cell) with superimposed distribution of neurons with the OS profile in red (mean 
19.9 ± 0.3 μ m, median = 19.7 μ m; 161 cell). (B) Histogram of soma diameter of neurons with the SD profile 
versus neurons with the RD profile in green (mean 20.7 ± 0.8 μ m, median = 20.1 μ m; 33 cell). (C) Histogram of 
soma diameter of neurons with the SD profile versus neurons with the ID profile in purple (mean 20.9 ± 0.8 μm, 
median = 20.1 μ m; 35 cell). (D) Histogram of soma diameter of VTD-unresponsive neurons (mean 
21.2 ± 0.4 μm, median = 20.4 μ m; 181 cell). Histograms are in 2 μ m bins. Vertical dotted line indicates the mean 
value for each distribution. All diameter measurements were taken from N = 8 mice and compared by Two-
tailed paired Student’s t-test, *P < 0.05 and ****P < 0.0001.
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and insensitive neurons within the OS and ID profiles were not significantly different. However, there was a clear 
bias in neurons with the SD and RD profiles towards capsaicin insensitivity, Fig. 4D.
As the SD profile occurred in a wide range of neuronal sizes, we examined the relationship between neuronal 
size and capsaicin sensitivity in the 111 neurons with the SD profile. Capsaicin-sensitive SD neurons had a smaller 
mean diameter than capsaicin-insensitive SD neurons, Fig. 4E, which is consistent with the known tendency of 
capsaicin sensitive neurons to be small to medium in diameter. Interestingly, capsaicin activated 35% (67 of 193) 
of VTD-unresponsive neurons which were all smaller than 30 μ m, Fig. 4F. From all the above, the SD and RD 
profiles are enriched in capsaicin-insensitive neurons.
The Veratridine SD and RD response profiles are under-represented in α, β-methylene ATP 
sensitive neurons. We next investigated how the four VTD response profiles correlate with sensitivity to 
another commonly used marker for nociceptors. α , β -methylene ATP is a specific agonist for P2× 3 receptors that 
marks the non-peptidergic population of nociceptors23–26. A preliminary experiment showed that responses to 1 μM 
α , β -methylene ATP (the EC50 for P2×3) can be completely inhibited by TNP-ATP, a selective P2×3 antagonist27  
(data not shown). Therefore, we applied 1 μ M α , β -methylene ATP with VTD to examine the relationship 
between the four VTD response profiles and sensitivity to α , β -methylene ATP. We applied the two agonists in 
alternate order, Fig 5A. As with capsaicin, the order in which VTD and α , β -methylene ATP were applied did not 
significantly influence the proportion of responding neurons nor the frequency of occurrence of VTD profiles, 
Supplementary Fig. S2. The frequency of occurrence of the four VTD response profiles was as obtained previ-
ously, Fig. 5C. The percentage of α , β -methylene ATP-responsive neurons (26%) was comparable to percentage 
of P2×3 positive neurons reported in immunolabelling studies23,26. α , β -methylene ATP-responsive neurons are 
approximately five times more likely to respond to VTD (289/344, 84%) than not (55/344, 16%), Fig. 5B. We next 
Figure 4. Veratridine SD and RD response profiles are under-represented in capsaicin-sensitive neurons. 
(A) Example traces from the two drug application protocols used. Top four traces from experiments where 
VTD was applied after 200 nM capsaicin. Bottom traces from experiments where VTD was applied before 1 μ M 
capsaicin. In the former case, a lower capsaicin concentration was used to avoid potential indirect suppression 
of VGSC by capsaicin42 (B). Capsaicin sensitivity and VTD response profiles of 579 neurons from N = 8 mice 
(combined from the two protocols in A). (C) The frequency of occurrence of the four VTD response profiles 
in the 386 VTD-responsive neurons shows the same order as in Fig. 2B. The OS profile is the most frequent 
(49.7 ± 4%) then the SD (26 ± 5%) followed by the ID (12 ± 2%) and the RD (11.1 ± 4%). (D) The proportion of 
capsaicin-sensitive neurons (closed bars) and capsaicin-insensitive neurons (open bars) within the four VTD 
response profiles. A larger proportion of SD (76.2 vs. 23.8 ± 6%) and RD neurons (76 vs. 24 ± 8%) is insensitive 
to capsaicin. OS (58.1 vs. 41.9 ± 5%) and ID neurons (55.3 vs. 43.4 ± 10%) show no difference. Frequency was 
from total number of neurons in each profile (n(SD) = 111, n(RD) = 30, n(ID) = 42, and n(OS) = 198 neurons). Data 
shown are mean ± SEM. One-way analysis of variance with Sidak’s post-test, ****P < 0.0001. (E) Diameter of 
SD neurons sensitive to capsaicin is smaller (closed bars, mean 19.9 ± 0.9 μ m, median 19.3 μ m, n = 33 cell) than 
diameter of capsaicin insensitive neurons (open bars; 24 ± 0.8 μ m, median 21 μ m, n = 78 cell). (F) Diameter of 
VTD-unresponsive neurons showing capsaicin-sensitive (closed bars, mean 19.7 ± 0.4 μ m, median 19.8 μ m,  
n = 67 cell) and capsaicin-insensitive populations (open bars, mean 21.6 ± 0.5 μ m, median 20.3 μ m, n = 126 
cell). In (E,F), dotted lines represent the mean. Two-tailed unpaired Student’s t-test, *P < 0.05 and **P < 0.01.
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examined the 912 VTD-responsive neurons for a relationship between each of the four VTD response profiles 
and α , β -methylene ATP sensitivity. The proportions of α , β -methylene ATP-sensitive and insensitive neurons 
within the OS and ID profiles were not significantly different, Fig. 5D. However, like with capsaicin, there was a 
clear bias in neurons with the SD and RD profiles towards α , β -methylene ATP insensitivity.
The SD subpopulation of neurons sensitive to α , β -methylene ATP had a smaller mean size (20 μ m) compared 
to the subpopulation insensitive to α , β -methylene ATP (23 μ m), Fig. 5E. Interestingly, 98% of VTD-unresponsive 
but α , β -methylene ATP-sensitive neurons were less than 30 μ m in diameter, Fig. 5F. From all the above, the SD 
and RD profiles are enriched in α , β -methylene ATP-insensitive neurons.
The Veratridine OS, ID and RD response profiles are enriched in nociceptors. Both the SD and 
RD response profiles were enriched in neurons insensitive to the two nociceptive markers; capsaicin and α , 
β -methylene ATP. This led us to hypothesise that these two response profiles could be functional markers for 
non-nociceptors, while the OS and ID response profiles could be functional markers for nociceptors. However, 
The OS and ID profiles did not occur preferentially in neurons sensitive to the nociceptive markers capsaicin 
(Fig. 4D) and α , β -methylene ATP (Fig. 5D). Nevertheless, it is possible that the OS neurons insensitive to capsa-
icin are the same neurons that are sensitive to α , β -methylene ATP and vice versa. To test this hypothesis, it was 
necessary to apply VTD, capsaicin and α , β -methylene ATP sequentially in the same protocol. We also wanted 
to profile VTD responses in C-low threshold mechanoreceptors because it was reported that this population is 
required for injury induced mechanical hypersensitivity28. This population expresses TRPA1 but not TRPV1 
nor P2×329; therefore we included allyl isothiocyanate (AITC, a specific TRPA1 agonist30–32) in our protocol. 
We applied the five agents in the calcium imaging protocol in two orders, Fig. 6A. The order of agents in the 
Figure 5. Veratridine SD and RD response profiles are under-represented in α, β-methylene ATP- sensitive 
neurons. (A) Example traces from the two drug application protocols used. (B) α , β -methylene ATP sensitivity 
and types of VTD response profile of the 1345 neurons sampled from N = 9 mice (combined from the two 
protocols in A). (C) The frequency of occurrence of VTD profiles in the 912 VTD-responsive neurons shows  
the same order as in Fig. 2B. The OS profile is the most frequent (51.4 ± 2%) then SD (28.1 ± 2%) followed by  
ID (10.1 ± 2%) and RD (9.8 ± 2%). (D) The proportion of α , β -methylene ATP-sensitive neurons (closed 
bars) and α , β -methylene ATP-insensitive neurons (open bars) within each of the four VTD response profiles. 
A larger proportion of SD (86.3 vs. 13.7 ± 6.6%) and RD neurons (68.9 vs. 31.1 ± 7) is insensitive to α , β 
-methylene ATP. Neurons with the OS (60 vs. 40 ± 2%) and ID (51.1 vs. 48.9 ± 8%) profile show no difference in 
the proportion of α , β -methylene ATP-sensitive and -insensitive neurons. Frequency was calculated from total 
number of neurons in each profile (n(SD) = 258, n(RD) = 82, n(ID) = 90, and n(OS) = 478 neurons). Data  
shown are mean ± SEM. One-way analysis of variance with Sidak’s post-test, ***P < 0.001 and ****P < 0.0001. 
(E) Histogram of diameter of neurons with the SD response profile showing that α , β -methylene ATP-sensitive 
neurons (closed bars, mean 20.2 ± 0.8 μ m, median 19.9 μ m, n = 32 cell) are significantly smaller than α , β - 
methylene ATP-insensitive neurons (open bars; mean 23.4 ± 0.5 μ m, median 21.3 μ m, n = 226 cell).  
(F) Histogram of diameter of neurons unresponsive to VTD showing α , β -methylene ATP-sensitive population 
(closed bars, mean 19.9 ± 0.6 μ m, median 19.2 μ m, n = 55 cell) and α , β -methylene ATP -insensitive population 
(open bars, mean 20.6 ± 0.2 μ m, median 20.2 μ m, n = 378 cell). In (E,F), dotted lines represent the mean. Two-
tailed unpaired Student’s t-test, *P < 0.05 and **P < 0.01.
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first protocol was; α , β -methylene ATP (1 μ M), AITC (100 μ M), VTD (30 μ M), capsaicin (200 nM) and 40 mM 
KCl. The order of agents in the second protocol was VTD, ATP, AITC, capsaicin and KCl. As with previous 
experiments (Figs 4 and 5), there was no significant difference in the proportion of responding neurons nor the 
frequency of occurrence of VTD profiles in both protocols, Supplementary Fig. S3.
Neurons sensitive to any of the three agonists were three times more likely to respond to VTD (333/442, 75%) 
than not (109/442, 25%), Fig. 6B. The frequency of occurrence of the four response profiles, Fig. 6C, was similar 
to previous values in Figs 3C, 4C and 5C. We next examined the 511 VTD-responsive neurons for a relationship 
between each of the four VTD response profiles and sensitivity to any of the three agonists. The three agonists 
divided the four VTD profiles into two groups. In one group is the SD response profile which continued to show a 
bias towards insensitivity to any of the three agonists, Fig. 6D. In the other group are the OS, ID and now the RD 
response profiles all showing a significant bias towards sensitivity to any of the three agonists, Fig. 6D.
The SD subpopulation of neurons sensitive to any of the three agonists have a smaller mean size (21 μ m) 
compared to the subpopulation insensitive to any of the three agonists (26 μ m), Fig. 6E. Interestingly, all neurons 
unresponsive to VTD but sensitive to any of the three agonists are smaller than 30 μ m in diameter, Fig. 6F. The 
percentage of responsive neurons to 100 μ M AITC (54%) is consistent with published findings31. The relation-
ship between VTD response profiles and sensitivity to AITC alone matches that for the three agonists combined 
(Supplementary Fig. S4). From all the above, the OS, ID and RD response profiles are enriched in neurons sensi-
tive to the nociceptive markers whereas the SD response profile is enriched in neurons insensitive to the nocice-
ptive markers, Fig. 7.
Figure 6. The Veratridine OS, ID and RD response profiles are enriched in nociceptors. (A) Example traces 
from the two drug application protocols used. (B) Drug sensitivity and VTD response profiles of 671 neurons 
from N = 7 mice. (C) The frequency of occurrence of VTD profiles in the 511 VTD-responsive neurons shows 
the same order as in Fig. 2B. The OS profile is the most frequent (50.6 ± 4.2%) then the SD profile (31.2 ± 4.8%) 
followed by RD (9.4 ± 0.8%) and ID (8 ± 1.8%) (D) The proportion of neurons sensitive to at least one agonist 
(closed bars) and neurons insensitive to any (open bars) within the four VTD response profiles. Larger 
proportion of SD neurons (71.6 vs. 28.4 ± 2.9%) is insensitive to any of the three agonists. In contrast, Larger 
proportion of RD neurons (96.7 vs. 3.3 ± 3.3%), ID (85.5 vs. 14.5 ± 7.7%) and OS (81 vs. 19 ± 4.6%) neurons are 
sensitive to at least one of the three agonists. Percentages were calculated from total number of neurons  
in each profile (n(SD) = 168, n(RD) = 44, n(ID) = 48, and n(OS) = 251 neuron). Data shown are mean ± SEM.  
One-way analysis of variance with Sidak’s post-test, ***P < 0.001 and ****P < 0.0001. (E) Diameter of SD 
neurons that are sensitive to at least one of the three agonists (closed bars, mean 21.2 ± 0.9 μ m, median 19.6 μ m, 
n = 51 cell) is significantly smaller than that of neurons insensitive to any of the three agonists (open bars; mean 
26.9 ± 0.7 μ m, median 28.3 μ m, n = 117 cell). (F) Diameter of VTD-unresponsive neurons sensitive to at least 
one agonist (closed bars are, mean 20.6 ± 0.4 μ m, median 20.7 μ m, n = 109 cell) and VTD-unresponsive neurons 
insensitive to any of the three agonists (open bars, mean 24.4 ± 1 μ m, median 24.3 μ m, n = 51 cell). In (E,F), 
dotted lines represent the mean. Two-tailed unpaired Student’s t-test, *P < 0.05.
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Figure 7. VTD response profiles correlate with classical functional markers of nociceptors. Neurons 
responding to at least one of the three agonists represent nociceptors and constitute 66% (442/671) of all DRG 
neurons in culture. Nociceptors with the OS, ID or RD VTD response profiles constitute 64% (282/442) of 
nociceptors (equivalent 282/671 = 42% of all neurons) compared to 12% (51/442) of nociceptors with the SD 
profile (equivalent to 51/671 = 8% of all neurons). Neurons insensitive to any of the three agonists represent 
non-nociceptors and constitute 34% (229/671) of all DRG neurons in culture. Non-nociceptors with the 
SD VTD response profile constitutes 51% (117/229) of non-nociceptors (equivalent to 117/671 = 17% of all 
neurons) compared to non-nociceptors with the OS, ID or RD VTD response profiles which constitute 27% 
(61/229) of non-nociceptors (equivalent 61/671 = 9% of all neurons).
Figure 8. Distribution of sensitivity to the three nociceptive markers within the four VTD response 
profiles. Venn diagram of the mean percentage of neurons with the SD, OS, RD and ID profiles that responded 
to allyl isothiocyanate (AITC, blue), capsaicin (CAP, red) and α , β -methylene ATP (α , β -CH2ATP, green). The 
percentage of neurons in each profile that did not respond to any of the agonists comprises the fourth non-
overlapping circle (white). Percentages were calculated from the total number of neurons in each VTD profile 
(SD: 168 cell, OS: 251 cell, RD: 44 cell, and ID: 48 cell) in experiment shown in Fig. 6B.
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We also examined the distribution of sensitivity to the three agonists among neurons with the four VTD pro-
files, Fig. 8. AITC sensitivity was the commonest feature of neurons that responded to one or more of the three 
agonists with the OS (88%), RD (86%), ID (81%) profiles but not the SD response profile (52%). Neurons with the 
SD response profile were approximately equally as likely to be capsaicin-sensitive (56%) or AITC-sensitive (52%).
Discussion
The present study examined VTD-elicited calcium responses in cultured adult mouse DRG neurons. VTD 
responses were heterogeneous. We categorised VTD responses into four distinct profiles based on the number of 
peaks and their decay rate. We report that VTD response profiles correlated with soma size and with commonly 
used pharmacological markers of nociceptor. To our knowledge this is the first detailed characterisation of VTD 
responses in DRG neurons.
What do VTD response profiles represent? Most of the studies that looked at the effect of VTD on voltage-gated 
ion channels used patch-clamp electrophysiology to examine the effect of VTD on sodium8,9, calcium33  
and potassium13 currents separately. In calcium imaging the measured response occurs in non-clamped neurons 
and is indirect to sodium entry. Therefore, the observed VTD response profiles are the net effect of VTD action on 
VGSCs at the resting membrane potential and the subsequent activation of other ion channel/exchanger classes. 
Therefore, it is important to keep in mind that although the response is initiated by VTD’s action on VGSCs, the 
overall response is shaped by; 1) Qualitative and quantitative differences in the “constellation” of sodium, potas-
sium and calcium voltage-gated ion channels subtypes in each DRG neuron. 2) Variations in calcium buffering 
mechanisms within each neuron which includes calcium efflux pathways, intracellular stores as well as calcium 
binding proteins34.
Our data shows that 30 μ M VTD evoked robust responses in approximately 70% of sensory neurons. A higher 
dose of 100 μ M VTD did not significantly increase the percentage of responding cells, Fig. 1D. Considering that 
higher doses of VTD are reported to have inhibitory effects on potassium channels, 30 μ M seems to be the most 
suitable concentration to use for an action primarily on VGSCs. VTD predominantly activates TTX-S VGSCs 
and our results are in agreement with this as TTX blocked most VTD responses (Fig. 1E–G). Voltage-clamp 
experiments on rat DRG neurons showed that VTD binds TTX-R VGSCs but dissociates at much faster rate than 
with TTX-S VGSCs10, which might explain why the TTX-R VTD responses we observed are transient in nature, 
Fig. 1F. It remains to be determined which of the TTX-R channels expressed in DRG neurons (i.e. Nav1.8 and 
Nav1.9) underlie the observed TTX-R VTD responses. We speculate that Nav1.9 is the most likely candidate 
because its expression is more restricted in DRG than Nav1.8 and this fits with low incidence of TTX-R VTD 
responses. Secondly, Nav1.9 activation potential is hyperpolarised allowing it to be open at the resting membrane 
potential which would allow VTD to act on the open channel. In contrast Nav1.8 activation potential is more 
depolarised and is unlikely to be open at resting membrane potential for VTD to affect it. In fact, it was reported 
that VTD did not activate a stable cell line expressing Nav1.835. Therefore, the contribution of Nav1.8 to VTD 
responses will be dependent upon prior action of VTD on TTX-S subtypes to depolarise the membrane. Since 
this would not happen in the presence of TTX; it is thus unlikely that Nav1.8 produces the TTX-R VTD responses 
in our experiment.
Importantly, the inability of VTD to activate stable cells expressing Nav1.8 may explain the about 25–30% of 
DRG neurons that are unresponsive to up to 100 μ M VTD, Fig 1D. We suggest that VTD-unresponsive neurons 
are so because they express mostly TTX-R and little TTX-S channels. In support of this the majority of neurons 
in this population are less than 30 μ m in diameter, Figs 3D, 4F, 5F and 6F. Additionally, the majority of neurons in 
this population (109/160, 68%) responded to at least one of the three nociceptor markers; capsaicin, AITC and α , 
β -methylene ATP, Fig. 6B. These 109 neurons constitute 25% of nociceptors (109/442, Fig. 6B). These neurons are 
likely to represent the small diameter, Nav1.8-rich and high-threshold neurons known as “silent nociceptors”36,37. 
Interestingly, silent nociceptors were estimated to be about 30% of all DRG neurons which is about the same 
percentage as the VTD-unresponsive population. This finding has significant implications for studies using ver-
atridine to activate DRG neurons as it means that up to 25% of nociceptors would not be assayed and their con-
tribution would be unknown.
We categorised VTD calcium responses in cultured DRG neurons into four profiles which we named SD, ID, 
RD and OS. The four profiles were observed in similar relative frequencies from cultures prepared over many 
months, from different patches of mice and by different researchers. Furthermore, the frequency of occurrence of 
VTD profiles was not affected by the order of applications of agonists in our experiments, Supplementary Figs 1–3. 
The stability of these profiles supports their suitability for use as functional signatures of subpopulations of DRG 
neurons in drug screens.
The most abundant response type is the OS (47–51% of VTD-responsive neurons) where VTD elicited oscil-
latory changes in [Ca]i levels. Interestingly, this is the only response profile VTD elicited in N2a and SH-SY5Y 
cells, Fig. 1B,C. A similar response profile was also reported in bovine chromaffin cells where VTD induced [Ca]i 
oscillations were dependant on the activation of TTX-S VGSC25. The oscillatory response in bovine chromaffin 
cells were long lasting (up to 40 min) even after VTD wash. A proportion of the OS responses in DRG neurons 
were persistent but most returned to baseline after VTD wash (not shown). Although SH-SY5Y, N2a and chro-
maffin cells12,38,39 all express Nav1.7, it is unlikely that the OS profile is a characteristic of Nav1.7 expressing cells 
as Nav1.7 is expressed in all DRG neurons whereas the OS profile occurs in about 50% of DRG neurons.
The other three types of VTD response profiles shared a profile characterised by a single peak but differed 
in their decay rate. The difference in the rate of signal decay could be due to a difference in the disassociation 
rates of VTD from the different VGSC subtypes. In addition, it has been shown that DRG neurons (particularly 
large-diameter neurons) produce calcium responses with slow decay rates (SD-like responses) when treated with 
VGKC blockers40. Therefore, differences in the decay rates of the VTD response profiles might be in part due to 
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some inhibitory effect of 30 μ M VTD on VGKCs. However, this is unlikely to be the main determinant of decay 
rates as it takes a much higher concentration of VTD (200 μ M) to inhibit VGKCs13.
A recent paper classified DRG neurons into 11 groups based on their mRNA profile29. Using their data (Figs 2 
and 4 in ref. 29) we predicted the distribution of sensitivity of DRG neurons to the three agonists used in this 
study based on the expression of their receptors, Fig. 9A. We compared this to the distribution of sensitivity we 
obtained from applying the concentrations of agonists we used, Fig. 9B. The two distributions have many similar-
ities. For example, all non-peptidergic neurons (represented by groups NP1–3 in ref. 29) are predicted to respond 
to AITC and in agreement we found that almost all α , β -methylene -ATP responded to 100 μ M AITC. Another 
similarity is that the TRPA1 positive population is the largest of the three agonists being 64% of DRG neurons by 
mRNA expression of TRPA1 and 54% by response to AITC. The percentage of AITC responders (54%) is almost 
identical to that reported by Barabas, M.E. et al.31 (55%). Therefore, the 10% higher percentage of TRPA1 express-
ing neurons must be due to the higher sensitivity of mRNA detection compared to functional imaging. The same 
reason is likely to explain the 9% higher percentage of neurons not responding to any of the agonists in our hands 
compared to what is predicted by mRNA expression. Capsaicin activated 25% DRG neurons in our experiments 
as opposed to a predicted 17% based on expression of TRPV1 receptor. The percentage of capsaicin responders in 
our experiments is in agreement with others (e.g.ref. 22). The higher percentage in our and others’ experiments 
could be due increased TRPV1 expression in cultured DRG neurons (> 1 day) compared to disassociated but 
non-cultured neurons as used for the mRNA sequencing study.
The data presented here raises several interesting questions. One question is what are the key molecular deter-
minants of each of the four VTD response profiles? Answering this allows the use of VTD profiles as readout for 
these ion channels and exchangers in high throughput functional screens on primary DRG neurons. Considering 
that 25–30% of nociceptors do not respond to 30 μ M VTD and that these are likely to be “silent” nociceptors, a 
second question is does the sensitization of DRG neurons by inflammation and nerve injury affect the number 
of VTD responsive neurons and their response profiles? Answering this question would allow the use of VTD 
Figure 9. Comparison of the sensitivity to the three nociceptive markers based on published RNASeq and 
our functional imaging data. (A) Venn diagram of the percentage of neurons expressing mRNA for receptors 
for the three agonists used according to data from Figs 2 and 4 of ref. 29. (B) Percentage of neurons responding 
to the three agonists from our experiment in Fig. 6. The classification of neuronal subpopulations is as per that 
in ref. 29. NP is non-peptidergic, PEP is peptidergic, NF is neurofilament heavy chain and TH for tyrosine 
hydroxylase.
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response profiles as readout of drugs’ ability to cause or reverse sensitisation of DRG neurons in high throughput 
screens. Such screens have the advantage of showing the net effect of a drug on the various classes of ion channels 
that give rise to VTD response profiles.
In conclusion, the present study shows that VTD induces calcium responses with heterogeneous profiles in 
TTX-S rich sensory neurons. VTD response profiles reflect distinct subpopulations of sensory neurons. These 
subpopulations overlap but are not identical to the subpopulations identified by classical functional nociceptive 
markers, Fig. 7. The OS and RD profiles are particularly enriched in nociceptors (neurons sensitive to at least 
one of the three agonists), while the SD profile is enriched in non-nociceptors (neurons insensitive to any of the 
three agonists). Our findings provide a detailed characterisation of VTD action on the different subsets of DRG 
neurons. Our work is relevant to studies and screens using VTD to activate DRG neurons.
Methods
DRG culture. Adult male C57BL/6 mice were sacrificed according to Schedule 1 of the Animal (Scientific pro-
cedure) Act 1986. DRG from all spinal levels were isolated and collected in PBS. PBS was then replaced with 1 mL 
Dulbecco’s Modified Eagle’s Medium/F12 (DMEM/F12) with Glutamax medium (Gibco) containing Dispase 
(1 mg/mL, Sigma) and Collagenase Type XI (0.6 mg/mL, Sigma) and left for 60 min at 37 °C and 5% CO2. DRGs 
were then triturated with a P1000 pipette tip. The cell suspension was carefully layered on top of 15% Bovine 
Serum Albumin (Melford) in DMEM/F12 and centrifuged at 800 g, for 10 min at room temperature with the 
minimum deceleration speed. The cell pellet was then washed in culture medium composed of DMEM/F12 plus 
10% Fetal Bovine Serum (FBS, Gibco), 100 units/ml penicillin and 100 μ g/ml streptomycin (Gibco). Cells were 
pelleted again, re-suspended in DRG culture medium and plated on glass coverslips coated with polyornithine 
(20 μ g/mL, Sigma). Cells were imaged 24 h after plating.
Calcium imaging. DRG neurons were loaded with 2 μ M Fura-2, AM (Molecular Probes) in standard extra-
cellular solution (140 mM NaCl, 4 mM KCl, 2 mM CaCl2, 10 mM HEPES, 5 mM glucose, pH = 7.4 with NaOH) 
and incubated for 30 min at 37 °C. Coverslips were then washed with standard extracellular ringer solution and 
left for 15 min at 37 °C and 5% CO2 and then for another 15 min at room temperature. Cells were excited with 
350 and 380 nm for ratiometric measurement of intracellular calcium using Cairn Dual OptoLED system. Cells 
were viewed using a 40X oil immersion objective. Images were acquired using a Hamamatsu C4742–95 camera. 
The cells were perfused with standard extracellular solution for at least 5 min to establish stable baseline. All 
recordings were performed at room temperature (23 ± 1 °C). Drugs were perfused at a flow rate of 3 mL/min. 
High potassium extracellular solution (104 mM NaCl, 40 mM KCl, 2 mM CaCl2, 10 mM HEPES, 5 mM glucose, 
pH = 7.4 with NaOH) was perfused at the end of the recordings, unless mentioned otherwise, as a depolarizing 
agent to identify viable neurons. Simple PCI 6 software was used for data acquisition, background subtraction and 
Fura-2,AM ratiometric measurement (F350/380 nm).
Compounds. All drugs were made to the required working dilution in standard extracellular ringer solu-
tion from stock solutions of the following concentrations: VTD (5 mM in ethanol, Abcam ab120279), Capsaicin 
(10 mM in ethanol, Tocris 0462), α , β -methylene ATP (10 mM in water, Sigma M6517), TTX (30 μ M in citrate 
buffer, Abcam Asc-054), TNP-ATP triethylammonium salt (10 mM in water, Tocris 2464), and allyl isothiocy-
anate (AITC; 100 μ M, Sigma 377430).
Data and statistical analysis. Neurons were identified by their responsiveness to 40 mM KCl. We defined 
a response as an increase in (F350/380) ratio of > 6 SD above the baseline. Differences in fluorescence (Δ F/F0) 
were calculated according to the following formula: F350/380 ratio in the presence of drug (F) during drug appli-
cation – the mean of F350/380 ratio of the 2.5 min prior to drug application (F0). Statistical analysis was per-
formed by calculating the mean percentage of responsive neurons (n) from the indicated number of mice for 
each figure (N). Sample mean of each set of experiments was calculated from multiple independent experiments 
(as specified in the result section) and compared to each other by one-way analysis of variance (ANOVA) with 
Sidaks’ post-test. Cell diameter measurements were performed using ImageJ software; cell area was obtained 
from a hand-drawn line delineating the soma. Soma diameter was then calculated using the following formula, 
Diameter = √ (4.Area/π ). For cell size comparison, two-tailed unpaired Student’s t-test was used for comparisons. 
All statistical analysis and comparisons were performed by GraphPad Prism software (version 7.00 for Windows). 
Area-proportional Venn diagrams were generated by BioVenn software41 and colour edited by CorelDRAW X8 
software.
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